跳至主要内容
临床试验/DRKS00033767
DRKS00033767尚未招募Unknown

Influence of different settings of the FiO2 controller under CPAP±Backup ventilation in small preterm infants in the weaning phase after respiratory distress syndrome – a prospective randomized clinical cross-over study.

niversitätsklinikum Ulm, Klinik für Kinder-und Jugendmedizin, Sektion Neonatologie und pädiatrische Intensivmedizin0 个研究点目标入组 36 人开始时间: 2024年5月10日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
5 Days 至 32 Weeks(—)
性别
All

入选标准

  • 1. Preterm infants with a gestational age <32 weeks and birth weight <1500g, receiving treatment in the neonatology section of the intensive care unit at the University Hospital Ulm and aged at least 120 hours.
  • 2. Requirement for non-invasive ventilation (CPAP or CPAP-Backup).
  • 3.FiO2 under CPAP±Backup = 21%.
  • 4. At least 4 episodes of hypoxemia (<80% SpO2) and/or apneas (>20 seconds duration) and/or bradycardias (heart rate <100/min) in the 12 hours preceding study enrollment.
  • 5. In the 12 hours preceding study enrollment, the number of provoked/intervention-requiring events (defined as SpO2 < 70% or heart rate <100/min) did not lead to escalation of non-invasive ventilation.
  • 6. Written consent from the legal guardians has been obtained.

排除标准

  • 1. Preterm and newborn infants with severe malformations affecting respiratory regulation (severe CNS malformations), lung function (e.g., lung hypoplasia, acute extra-alveolar air such as pneumothorax and pulmonary interstitial emphysema, diaphragmatic hernias), or cardiovascular function significantly (congenital cyanotic heart defects, severe septic shock).
  • 2. Postnatal age <120 hours (often acute deterioration in the early phase of respiratory distress syndrome and to adhere to the minimal-handling principle during the critical phase to prevent intraventricular hemorrhage).
  • 3. Initiation of treatment for an acute clinical infection <72 hours before study enrollment.
  • 4. Escalation of non-invasive ventilation in the 12 hours preceding study enrollment due to the number of provoked/intervention-requiring events (defined as SpO2 <70% or heart rate <100/min).
  • 5. Planned blood transfusion or surgery during the study phase.
  • 6. Study initiation <48 hours after immunization.
  • 7. Retinopathy of prematurity (ROP) examination on study days.

研究者

发起方
niversitätsklinikum Ulm, Klinik für Kinder-und Jugendmedizin, Sektion Neonatologie und pädiatrische Intensivmedizin

相似试验